We’re excited to attend the National Association of Specialty Pharmacy (NASP) 2024 Annual Meeting in Nashville this week, where we will showcase data on treatment patterns for people with #ALS. We look forward to connecting with the ALS community to discuss how to help improve the patient journey for people living with ALS. Learn more about our presence at #NASPAnnual2024 here: https://bit.ly/4dBA0E1
Mitsubishi Tanabe Pharma America
Pharmaceutical Manufacturing
Jersey City, NJ 14,816 followers
About us
We are taking on the challenges of complex and debilitating conditions and are committed to meeting the needs of people suffering from serious and often life-threatening illnesses. Today, we are focused on driving scientific discovery in many areas. Our focus remains on bringing treatment to people living with ALS as we strive to make a meaningful difference in their lives. Many people living with amyotrophic lateral sclerosis (ALS) have unmet medical needs. We are committed to doing our best to find solutions that may help address those needs. We continue to expand our work to deepen our understanding of ALS, explore potential biomarkers to aid in further research and seek new answers. Every day we tackle tough challenges in science and medicine. Our teams work diligently to develop smart options that will enable healthcare providers to offer safe and effective treatments for devastating illnesses. Please see our LinkedIn community guidelines here: http://www.mt-pharma-america.com/pdf/LinkedIn-Community-Guidelines.pdf
- Website
-
https://www.mt-pharma-america.com/
External link for Mitsubishi Tanabe Pharma America
- Industry
- Pharmaceutical Manufacturing
- Company size
- 51-200 employees
- Headquarters
- Jersey City, NJ
- Type
- Privately Held
- Founded
- 2016
- Specialties
- pharmaceutical products, amyotrophic lateral sclerosis, rare disease, innovation, research and development, and global business
Locations
-
Primary
Jersey City, NJ, US
Employees at Mitsubishi Tanabe Pharma America
-
Greg Fersko
Biopharma Strategy | Business Development | M&A | Market Access | Lifecycle Management
-
Howard Levine
Associate Director,Healthcare Intelligence | Digital Biomarkers | Wearables | Decentralized Clinical Trials 🏠 | Beyond the Pill 💊 | Health IoT 📱
-
Glenn Bubb
-
Lia Thornton
Sr. Director, Multichannel Marketing & Patient Support at Mitsubishi Tanabe Pharma America
Updates
-
Get the latest findings from our observational #ALS Go-Digital study during the Digital Health & AI Innovation Summit (DHAI) in Boston, MA. Our very own Sharon Tamir will present key data from our ongoing collaboration with the Muscular Dystrophy Association. #DHAI24
-
Our team was honored to attend The Bourque Family Foundation's Captain's Ball 2024, a night dedicated to honoring Pete Frates’ legacy of ALS advocacy that continues to inspire our work. Thank you to Greg Mitchell, susie yong, Ivona Filic, and Bruce Myers, MBA for representing MTPA on the red carpet. #ALSawareness
-
Today at the #MDSCongress, we’re presenting new Phase 3 BouNDless study data from our #Parkinsonsdisease research. Read more: https://bit.ly/4eMIfy5
-
We’re looking forward to attending the International Parkinson and Movement Disorder Society Congress, where we’ll share seven posters on our latest #Parkinsonsdisease research. Learn more about MTPA’s presentations at #MDSCongress here: https://bit.ly/3U8XtFR
-
Our colleagues at Mitsubishi Tanabe Pharma Europe Limited recently participated in the #AmsterdamCitySwim 2024 to raise awareness for #ALS. Dr. Ingrid Tacken, Senior Manager Medical Affairs & Medical Science Liaison, Mitsubishi Tanabe Pharma GmbH joined over 2,500 swimmers who jumped into the canals of Amsterdam to support Stichting ALS Nederland. Thank you to everyone who participated to help make a difference in the lives of people living with ALS. #ACS2024
-
We are proud to have participated in the Les Turner ALS Foundation Walk for Life event earlier this month! Our team remains committed to supporting the #ALS community and making a meaningful impact through scientific research. #MTPAWalksforALS
-
Through the ALS Go-Digital study with Muscular Dystrophy Association, we’ve developed ALS HANDs, a mobile app featuring gamified tests to evaluate a variety of fine motor skills to help clinicians and patients track progression of the disease.
-
Our 300-year scientific legacy is a core part of our identity, and we continue it through our unwavering commitment to discovering scientific breakthroughs that can help meet the needs of people with debilitating diseases. Learn how: https://bit.ly/3M3h2e0
-
At MTPA, we take pride in the vibrant diversity of our employees. In celebration of #NationalHispanicHeritageMonth, we spotlight the remarkable contributions of our Latin communities. Their dedication, unique perspectives, and invaluable skills are instrumental in driving scientific discovery and solving complex problems in science and medicine. As a Japanese company with a 300-year history, we know that by embracing diverse viewpoints and talents, we foster an environment of innovation and a culture of excellence. Join us in celebrating the rich cultural heritage of our Latin team members and explore opportunities to be a part of our dynamic team: https://bit.ly/4gvVpkr #DEI